NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beeline Medicines

Beeline Medicines

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://beelinemedicines.com/

Last Round

Series A

Jun 30, 2026

Total Funding Raised

$1.15B

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Beeline Medicines is a biotechnology company that develops precision therapies for autoimmune and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug developmentautoimmune diseaseprecision medicineclinical trialssmall-molecule inhibitorbiotech startuptherapeutic pipelinesystemic lupus erythematosuslupusatopic dermatitisdrug discoveryin-licensingbiopharmaclinical-stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beeline Medicines Comps

Public and private peers based on sector, stage, and business model.

Beeline Medicines comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beeline Medicines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 30, 2026
Series AApr 15, 2026
Series AJul 1, 2025

Key People

Founding team and executive leadership

Saqib Islam

Chief Executive Officer

Executive Team

Badreddin Edris

President & Chief Operating Officer

Executive Team

Beeline Medicines Investors

Notable investors and investment history

Beeline Medicines investors
InvestorRounds
CPP InvestmentsSeries A
Bain Capital, LPSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2026

    $126M round with participation from Bain Capital and CPP Investments.

  • Apr 16, 2026

    $300M round raised.

Beeline Medicines Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beeline Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beeline Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range35
Year Founded2025
Last FundingJun 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.